28th Jun 2018 7:00 am |
RNS |
Notification of Major Interest in Shares |
27th Jun 2018 7:00 am |
RNS |
Notification of Major Interest in Shares |
22nd Jun 2018 7:00 am |
RNS |
Notification of Major Interest in Shares |
21st Jun 2018 7:00 am |
RNS |
Notification of Major Interest in Shares |
20th Jun 2018 2:00 pm |
RNS |
Notification of Major Interest in Shares |
20th Jun 2018 11:05 am |
RNS |
Second Price Monitoring Extn |
20th Jun 2018 11:00 am |
RNS |
Price Monitoring Extension |
20th Jun 2018 7:00 am |
RNS |
Notification of Major Interest in Shares |
19th Jun 2018 9:05 am |
RNS |
Second Price Monitoring Extn |
19th Jun 2018 9:00 am |
RNS |
Price Monitoring Extension |
18th Jun 2018 7:00 am |
RNS |
Positive Results for Phase IIb FLU-v Field Study |
23rd May 2018 12:30 pm |
RNS |
Result of AGM |
27th Apr 2018 2:00 pm |
RNS |
2017 Annual Report and Financial Statements |
19th Apr 2018 7:01 am |
RNS |
Audited 2017 Preliminary Results |
19th Apr 2018 7:00 am |
RNS |
Chief Executive Officer Steps Down |
10th Apr 2018 7:00 am |
RNS |
Statement regarding share price |
6th Apr 2018 7:00 am |
RNS |
Notice of Preliminary Results |
5th Apr 2018 12:00 pm |
RNS |
Directors' Dealings |
26th Mar 2018 7:00 am |
RNS |
Initial results from a Phase IIb study of FLU-v |
16th Jan 2018 7:00 am |
RNS |
Award of Share Options |
9th Jan 2018 7:00 am |
RNS |
Directors' Dealings |
21st Dec 2017 7:00 am |
RNS |
Award of Share Options |
14th Dec 2017 2:00 pm |
RNS |
Director's Dealings |
30th Oct 2017 7:00 am |
RNS |
Directorate Change |
5th Oct 2017 7:00 am |
RNS |
Directors' Dealings |
21st Sep 2017 7:00 am |
RNS |
Half-year Report |
10th Jul 2017 7:00 am |
RNS |
Directors' Dealings |
20th Jun 2017 7:00 am |
RNS |
Board Change |
24th May 2017 2:00 pm |
RNS |
Result of Annual General Meeting |
18th May 2017 7:00 am |
RNS |
Award of Deferred Bonus Share Options |
28th Apr 2017 2:00 pm |
RNS |
2016 Annual Report and Financial Statements |
20th Apr 2017 7:00 am |
RNS |
Audited 2016 Preliminary Results |
13th Apr 2017 7:00 am |
RNS |
Trading Update |
5th Apr 2017 7:00 am |
RNS |
Directors' Dealings |
21st Feb 2017 4:30 pm |
RNS |
Initiation of a Phase I clinical trial with AGS-v |
9th Feb 2017 7:00 am |
RNS |
Data from PrEP Biopharm's Ph. IIa clinical studies |
5th Jan 2017 7:00 am |
RNS |
Directors' Dealings |
30th Dec 2016 7:00 am |
RNS |
Change of auditor |
27th Oct 2016 7:00 am |
RNS |
Notification of Major Interest in Shares |
12th Oct 2016 7:00 am |
RNS |
Directors' Dealings |